CFDE Workbench
Information PortalData PortalKnowledge Portal
Search
Graph
Enrichment
Cross
Assistant
Data Matrix
Use Cases
Tools & Workflows
Submit
Documentation
CFDE Workbench

Alpha-2B adrenergic receptor  (Protein)

Uniprotkb:P18089
Id:787c3a31-3eba-502b-b6de-077f4b762ee3

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Alpha-2B adrenergic receptor 's neighborhood in the knowledge graph.

Submit
Results found

Linked to

 

Label

Description

 

Knowledge Graph Assertion

Fipamezole bioactivity Alpha-2B adrenergic receptor

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

(4,5-Dihydro-oxazol-2-yl)-(3-propyl-bicyclo[2.2.1]hept-2-yl)-amine bioactivity Alpha-2B adrenergic receptor

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Pramipexole bioactivity Alpha-2B adrenergic receptor

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

(3-Benzyl-bicyclo[2.2.1]hept-2-yl)-(4,5-dihydro-oxazol-2-yl)-amine bioactivity Alpha-2B adrenergic receptor

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

2-(4-(4-(2-(2-fluoroethoxy)phenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)-dione bioactivity Alpha-2B adrenergic receptor

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

(6S*,6aR*)-4-(6-Propyl-1a,6-dihydro-1H-cyclopropa[a]inden-6a-yl)-1H-imidazole bioactivity Alpha-2B adrenergic receptor

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

3-[2-(3,4-Dihydro-1H-benzo[4,5]furo[3,2-c]pyridin-2-yl)-ethyl]-2,6-dimethyl-pyrido[1,2-a]pyrimidin-4-one bioactivity Alpha-2B adrenergic receptor

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

spiroxatrine bioactivity Alpha-2B adrenergic receptor

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

2-(2,3-dihydro-2-methoxy-1,4-benzodioxin-2-yl)-4,5-dihydro-1H-imidazole bioactivity Alpha-2B adrenergic receptor

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one (Resperidone) bioactivity Alpha-2B adrenergic receptor

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    Fipamezole bioactivity Alpha-2B adrenergic receptor

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    (4,5-Dihydro-oxazol-2-yl)-(3-propyl-bicyclo[2.2.1]hept-2-yl)-amine bioactivity Alpha-2B adrenergic receptor

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    Pramipexole bioactivity Alpha-2B adrenergic receptor

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    (3-Benzyl-bicyclo[2.2.1]hept-2-yl)-(4,5-dihydro-oxazol-2-yl)-amine bioactivity Alpha-2B adrenergic receptor

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    2-(4-(4-(2-(2-fluoroethoxy)phenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)-dione bioactivity Alpha-2B adrenergic receptor

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    (6S*,6aR*)-4-(6-Propyl-1a,6-dihydro-1H-cyclopropa[a]inden-6a-yl)-1H-imidazole bioactivity Alpha-2B adrenergic receptor

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    3-[2-(3,4-Dihydro-1H-benzo[4,5]furo[3,2-c]pyridin-2-yl)-ethyl]-2,6-dimethyl-pyrido[1,2-a]pyrimidin-4-one bioactivity Alpha-2B adrenergic receptor

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    spiroxatrine bioactivity Alpha-2B adrenergic receptor

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    2-(2,3-dihydro-2-methoxy-1,4-benzodioxin-2-yl)-4,5-dihydro-1H-imidazole bioactivity Alpha-2B adrenergic receptor

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

  • Knowledge Graph Assertion

    3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one (Resperidone) bioactivity Alpha-2B adrenergic receptor

    Knowledge Graph Assertion (Entity type)

    A Knowledge Graph Assertion from IDG

    • DISPLAY PER PAGE
    CFDE Workbench
    Report a bug
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    @CFDE Workbench 2025
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    Consortium
    About the CFDECF ProgramsCFDE CentersPartnershipsPilot Projects
    Community
    Workbench TutorialTraining & OutreachDocumentationGet QR CodesFunding Opportunities
    Resources
    Data & MetadataToolsChatbotUse CasesPublications
    CFDE Workbench
    Report a bug
    The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
    @CFDE Workbench 2025
    This repository is under review for potential modification in compliance with Administration directives.